Skip to main content
. 2013 Dec 20;13:340. doi: 10.1186/1471-244X-13-340

Table 1.

LAI antipsychotics available in France (when the survey was completed)

LAI second-generation antipsychotics Risperidone microsphere
Olanzapine pamoate
LAI first-generation antipsychotics Haloperidol decanoate
Zuclopenthixol decanoate
Flupentixol decanoate
Fluphenazine decanoate
Pipotiazine palmitate

Note: as paliperidone palmitate had a marketing authorization date after the development of these guidelines, it could not be taken into account.